Considering that IL-36α is a pro-inflammatory interleukin, and chronic inflammation is a well-known factor in carcinogenesis, it therefore appears that with the degree of histological differentiation of ovarian cancer, there is an increase in the inflammatory process, and thus an increase in the concentration of IL-36α, as a mediator of inflammation. This evidence concerns the gene IL36A and ovarian cancer.